Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial

by Jianming Xu, Nong Xu, Yuxian Bai, Rongrui Liu, Chenyu Mao, Hong Sui, Xiaofei Wang, Qian Jiang, Yiwei Dou
Published 2021-01-01

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancerResearch in context

by Yan Wang, Chuanhua Zhao, Lianpeng Chang, Ru Jia, Rongrui Liu, Yun Zhang, Xuan Gao, Jin Li, Rongrong Chen, Xuefeng Xia, Ajaz Bulbul, Hatim Husain, Yanfang Guan, Xin Yi, Jianming Xu
Published 2019-05-01